Results 191 to 200 of about 22,335 (252)
Metabolic dysfunction associated steatotic liver disease: mechanisms, diagnosis, and management in adults. [PDF]
Reinson T +5 more
europepmc +1 more source
MAFLD/MASLD: Past, Present, and Future
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD), also known as nonalcoholic fatty liver disease and metabolic dysfunction‐associated fatty liver disease, affects more than 30% of the global adult population and has become one of the leading causes of cirrhosis and hepatocellular carcinoma.
Vincent Wai‐Sun Wong
wiley +1 more source
Considerations in Imaging-Based Assessment of Steatotic Liver Disease to Enhance Harmonization, Longitudinal Interpretation, and Clinical Implementation. [PDF]
Guo J, Yu Q, Zhang P.
europepmc +1 more source
ABSTRACT Background Although numerous noninvasive indices have been proposed to assess significant fibrosis (SF), none have been validated specifically in young adults with metabolic dysfunction‐associated steatotic liver disease (MASLD). This study evaluated their performance in younger patients across two cohorts with distinct screening goals ...
Ahlim Lee +6 more
wiley +1 more source
The Cardiovascular Risk Paradox in Normal-Weight Steatotic Liver Disease Beyond Body Mass Index-Based Detection. [PDF]
Hirooka M +13 more
europepmc +1 more source
ABSTRACT Background Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer‐related deaths in Malaysia. Early detection increases the likelihood of curative treatment and improves survival. This consensus document aims to provide evidence‐based, locally relevant recommendations for the prevention and early detection of HCC.
Su Yin Lau +18 more
wiley +1 more source
Gut microbiota and pediatric metabolic dysfunction-associated steatotic liver disease: clinical evidence and therapeutic implications. [PDF]
Nair B +5 more
europepmc +1 more source
ABSTRACT Background Chronic hepatitis B virus (HBV) remains a major cause of hepatocellular carcinoma (HCC) in Australia, despite the availability of effective, subsidized antiviral therapy. We aimed to describe the clinical characteristics, HBV care cascade, and outcomes among people with HBV‐related HCC in Victoria, Australia.
Dina Moussa +23 more
wiley +1 more source
Correction: Metabolic dysfunction associated steatotic liver disease: mechanisms, diagnosis, and management in adults. [PDF]
europepmc +1 more source

